Paliperidone

Records for this ingredient, by country (identity only).

ATC N05AX13 · 12 markets · 366 records

Paliperidone 12 markets · 366 records Forms
Filters

US 86 records · 12 shown of 16 Source openFDA NDC Directory · Data as of 2026-10-23

  • 6 mgtablet · extended-releaseINVEGAManufacturer: Ajanta Pharma USA Inc.、Manufacturer: Alembic Pharmaceuticals Inc.、Manufacturer: Alembic Pharmaceuticals Lim…、Manufacturer: American Health Packaging、Manufacturer: Amneal Pharmaceuticals LLC、Manufacturer: ANI Pharmaceuticals, Inc.、Manufacturer: Archis Pharma LLC、Manufacturer: AvKARE +10 also in ES·GB·CN
    +4Other 4 marketsAUTWCASG
  • 3 mgtablet · extended-releaseINVEGAManufacturer: Ajanta Pharma USA Inc.、Manufacturer: Alembic Pharmaceuticals Inc.、Manufacturer: Alembic Pharmaceuticals Lim…、Manufacturer: American Health Packaging、Manufacturer: Amneal Pharmaceuticals LLC、Manufacturer: ANI Pharmaceuticals, Inc.、Manufacturer: Archis Pharma LLC、Manufacturer: AvKARE +10 also in ES·GB·CN
    +4Other 4 marketsAUTWCASG
  • 9 mgtablet · extended-releaseINVEGAManufacturer: Ajanta Pharma USA Inc.、Manufacturer: Alembic Pharmaceuticals Inc.、Manufacturer: Alembic Pharmaceuticals Lim…、Manufacturer: Amneal Pharmaceuticals LLC、Manufacturer: ANI Pharmaceuticals, Inc.、Manufacturer: Archis Pharma LLC、Manufacturer: AvKARE、Manufacturer: Bryant Ranch Prepack +8 also in ES·GB·CN
    +4Other 4 marketsAUTWCASG
  • 1.5 mgtablet · extended-releaseINVEGAManufacturer: Ajanta Pharma USA Inc.、Manufacturer: Alembic Pharmaceuticals Inc.、Manufacturer: Alembic Pharmaceuticals Lim…、Manufacturer: Amneal Pharmaceuticals LLC、Manufacturer: ANI Pharmaceuticals, Inc.、Manufacturer: AvKARE、Manufacturer: Bryant Ranch Prepack、Manufacturer: Camber Pharmaceuticals, Inc +5
  • 234 mg/1.5 mLinjectionErzofri extended-releaseINVEGA SUSTENNA
  • 156 mg per mL / per unit basis not statedinjectionErzofri extended-releaseINVEGA SUSTENNA
  • 117 mg/0.75 mLinjectionErzofri extended-releaseINVEGA SUSTENNA
  • 78 mg/0.5 mLinjectionErzofri extended-releaseINVEGA SUSTENNA
  • 39 mg/0.25 mLinjectionErzofri extended-releaseINVEGA SUSTENNA
  • 1,560 mg/5 mLinjection · extended-releaseINVEGA HAFYERA
  • 1,092 mg/3.5 mLinjection · extended-releaseINVEGA HAFYERA
  • 819 mg/2.63 mLinjection · extended-releaseINVEGA TRINZA
Other strengths: 4 · 1 dosage forms Otras concentraciones: 4 · 1 formas farmacéuticas 其余规格 4 个 · 涉及 1 种剂型 其餘規格 4 個 · 涉及 1 種劑型 · 546 mg/1.75 mL、410 mg/1.32 mL、351 mg/2.25 mL、273 mg/0.88 mL
injection · 4546 mg/1.75 mL · extended-release410 mg/1.32 mL · extended-release351 mg/2.25 mL273 mg/0.88 mL · extended-release

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

ES 56 records · 12 shown of 14 Source CIMA (AEMPS) · Data as of live

  • 6 mgtablet · extended-releaseINPALIXINVEGA、PALIPERIDONA ALTER、PALIPERIDONA CINFA、PALIPERIDONA RATIOPHARM、PALIPERIDONA SANDOZ、PALIPERIDONA TAD、PALIPERIDONA TEVA-RATIOPHARM、PARNIDO also in US·GB·CN
    +4Other 4 marketsAUTWCASG
  • 3 mgtablet · extended-releaseINPALIXINVEGA、PALIPERIDONA ALTER、PALIPERIDONA CINFA、PALIPERIDONA RATIOPHARM、PALIPERIDONA SANDOZ、PALIPERIDONA TAD、PALIPERIDONA TEVA-RATIOPHARM、PARNIDO also in US·GB·CN
    +4Other 4 marketsAUTWCASG
  • 9 mgtablet · extended-releaseINPALIXINVEGA、PALIPERIDONA ALTER、PALIPERIDONA CINFA、PALIPERIDONA RATIOPHARM、PALIPERIDONA SANDOZ、PALIPERIDONA TAD、PALIPERIDONA TEVA-RATIOPHARM、PARNIDO also in US·GB·CN
    +4Other 4 marketsAUTWCASG
  • 100 mg per mL / per unit basis not statedinjection · extended-releaseNIAPELFPALIPERIDONA STADA PRECARGADA、PALIPERIDONA TEVA、PALMEUX PRECARGADA、XEPLION
  • 75 mg per mL / per unit basis not statedinjection · extended-releaseNIAPELFPALIPERIDONA STADA PRECARGADA、PALIPERIDONA TEVA、PALMEUX PRECARGADA、XEPLION
  • 150 mg per mL / per unit basis not statedinjection · extended-releaseNIAPELFPALIPERIDONA STADA PRECARGADA、PALIPERIDONA TEVA、PALMEUX PRECARGADA
  • 50 mg per mL / per unit basis not statedinjection · extended-releaseNIAPELFPALIPERIDONA STADA PRECARGADA、PALMEUX PRECARGADA、XEPLION
  • 25 mg per mL / per unit basis not statedinjection · extended-releaseNIAPELF
  • 1,000 mg per mL / per unit basis not statedinjection · extended-releaseBYANNLI PRECARGADA
  • 700 mg per mL / per unit basis not statedinjection · extended-releaseBYANNLI PRECARGADA
  • 525 mg per mL / per unit basis not statedinjection · extended-releaseTREVICTA
  • 350 mg per mL / per unit basis not statedinjection · extended-releaseTREVICTA
Other strengths: 2 · 1 dosage forms Otras concentraciones: 2 · 1 formas farmacéuticas 其余规格 2 个 · 涉及 1 种剂型 其餘規格 2 個 · 涉及 1 種劑型

GB 46 records · 12 shown of 14 Source NHSBSA dm+d · Data as of 2026-10-19

Other strengths: 2 · 1 dosage forms Otras concentraciones: 2 · 1 formas farmacéuticas 其余规格 2 个 · 涉及 1 种剂型 其餘規格 2 個 · 涉及 1 種劑型 · 263 mg/1.315 mL、175 mg/0.875 mL
injection · 2263 mg/1.315 mL · extended-release175 mg/0.875 mL · extended-release

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CN 39 records · 6 shown of 6 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 6 mgtablet · extended-release芮达帕利哌酮Manufacturer: SunPharmaceuticalIndustries…、Manufacturer: 华润双鹤利民药业(济南)有限公司、Manufacturer: 江苏豪森药业集团有限公司、Manufacturer: 深圳市泛谷药业股份有限公司、Manufacturer: 石药集团欧意药业有限公司 also in US·ES·GB
    +4Other 4 marketsAUTWCASG
  • 3 mgtablet · extended-release芮达帕利哌酮Manufacturer: SunPharmaceuticalIndustries…、Manufacturer: 华润双鹤利民药业(济南)有限公司、Manufacturer: 江苏豪森药业集团有限公司、Manufacturer: 深圳市泛谷药业股份有限公司、Manufacturer: 石药集团欧意药业有限公司 also in US·ES·GB
    +4Other 4 marketsAUTWCASG
  • 9 mgtablet · extended-release芮达帕利哌酮 also in US·ES·GB
    +4Other 4 marketsAUTWCASG
  • 150 mg/1.5 mLinjection善思达帕利哌酮Manufacturer: 绿叶嘉奥制药石家庄有限公司、Manufacturer: 齐鲁制药有限公司 also in GB
  • 100 mg/1 mLinjection善思达帕利哌酮Manufacturer: 绿叶嘉奥制药石家庄有限公司、Manufacturer: 齐鲁制药有限公司
  • 75 mg/0.75 mLinjection善思达帕利哌酮Manufacturer: 绿叶嘉奥制药石家庄有限公司、Manufacturer: 齐鲁制药有限公司

HK 29 records · 0 shown of 0 Source 衞生署藥物辦公室(香港)註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

29 records · 0 manufacturers 29 registros · 0 fabricantes 29 个记录 · 0 个厂家 29 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名COMPASSIA PROLONGED-RELEASE SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 100MG/1ML ×16INVEGA Extended Release Tablets 3mg ×27INVEGA HAFYERA PROLONGED-RELEASE SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 1000MG/5ML ×4INVEGA SUSTENNA PROLONGED RELEASE SUSP FOR IM INJ. 100MG ×16INVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR INJECTION 175MG ×16PALIPERIDONE EXTENDED-RELEASE TABLETS 3MG ×9PALIPERIDONE PROLONGED-RELEASE TABLETS 3MG ×9PALIPERIDONE TEVA PROLONGED-RELEASE SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 100MG/1ML ×9

and 1 more (0 manufacturers) y 1 más (0 fabricantes) 还有 1 个(0 个厂家) 還有 1 個(0 個廠商)

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

AU 22 records · 12 shown of 15 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 6 mgtablet · extended-releaseINVEGAINVEGA paliperidone 3mg modified release tablet blister pack also in US·ES·GB
    +4Other 4 marketsCNTWCASG
    unknown
  • 3 mgtablet · extended-releaseINVEGAINVEGA paliperidone 3mg modified release tablet blister pack also in US·ES·GB
    +4Other 4 marketsCNTWCASG
    unknown
  • 9 mgtablet · extended-releaseINVEGAINVEGA paliperidone 3mg modified release tablet blister pack also in US·ES·GB
    +4Other 4 marketsCNTWCASG
    unknown
  • 100 mg per mL / per unit basis not statedinjection · extended-releaseINVEGA SUSTENNA
  • 75 mg per mL / per unit basis not statedinjection · extended-releaseINVEGA SUSTENNA
  • 150 mg per mL / per unit basis not statedinjection · extended-releaseINVEGA SUSTENNA
  • 50 mg per mL / per unit basis not statedinjection · extended-releaseINVEGA SUSTENNA
  • 1,000 mg/5 mLinjection · extended-releaseINVEGA HAFYERA also in GB
  • 700 mg/3.5 mLinjection · extended-releaseINVEGA HAFYERA also in GB
  • 525 mg/2.625 mLinjection · extended-releaseINVEGA TRINZA also in GB
  • 350 mg/1.75 mLinjection · extended-releaseINVEGA TRINZA also in GB
  • 263 mg/1.315 mLinjection · extended-releaseINVEGA TRINZA also in GB
Other strengths: 3 · 2 dosage forms Otras concentraciones: 3 · 2 formas farmacéuticas 其余规格 3 个 · 涉及 2 种剂型 其餘規格 3 個 · 涉及 2 種劑型 · 175 mg/0.875 mL
tablet · 112 mg · extended-release
injection · 2175 mg/0.875 mL · extended-release25 mg · extended-release

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名INVEGA ×2INVEGA HAFYERA ×2INVEGA SUSTENNA ×2INVEGA TRINZA ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

TW 13 records · 3 shown of 3 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

  • 6 mgtablet · extended-releaseBerydone Extended-Release Tablets 9mgDonvex CORS Tablets 6 mg、Pardone Extended-Release Tablets 6mg、佩里波持續性藥效錠6毫克、倍理通持續性藥效錠6毫克、豪思得持續性藥效錠6毫克 also in US·ES·GB
    +4Other 4 marketsCNAUCASG
  • 3 mgtablet · extended-releaseBerydone Extended-Release Tablets 9mgDonvex CORS Tablets 6 mg、Pardone Extended-Release Tablets 6mg、佩里波持續性藥效錠3毫克、倍理通持續性藥效錠3毫克、豪思得持續性藥效錠3毫克 also in US·ES·GB
    +4Other 4 marketsCNAUCASG
  • 9 mgtablet · extended-releaseBerydone Extended-Release Tablets 9mgDonvex CORS Tablets 6 mg、Pardone Extended-Release Tablets 6mg、佩里波持續性藥效錠9毫克、倍理通持續性藥效錠9毫克、豪思得持續性藥效錠9毫克 also in US·ES·GB
    +4Other 4 marketsCNAUCASG
4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名INVEGA Extended Release Tablets 3mg ×54Paliperidone Teva Prolonged Release Suspension For Injection 100mg/mL ×1思維佳持續性藥效錠 3 毫克 ×2思維佳持續性藥效錠6毫克 ×2思維佳持續性藥效錠9毫克 ×2梯瓦思穩寧持續性長效注射懸液劑100毫克/毫升 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CA 11 records · 9 shown of 9 Source Health Canada Drug Product Databas · Data as of 2026-10-23

SG 6 records · 3 shown of 3 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

EU 5 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

5 records · 0 manufacturers 5 registros · 0 fabricantes 5 个记录 · 0 个厂家 5 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名BYANNLI ×1INVEGA ×2NIAPELF ×2TREVICTA ×2XEPLION ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 3 records · 3 shown of 3 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.